Brad T. Tinkle, M.D., Ph.D., is a clinical geneticist at Peyton Manning Children’s Hospital in Indianapolis, Indiana. Most recently, he was the Medical Director of Clinical Genetics at Advocate Children’s Hospital in Chicagoland. His clinics included Ehlers-Danlos (for adults, children, and families) and pediatric Down’s Syndrome.
Prior to Advocate, Dr. Tinkle was a clinical and clinical molecular geneticist at Cincinnati Children’s Hospital Medical Center (CCHMC). He specializes in caring for individuals with heritable connective tissue disorders such as Ehlers-Danlos syndromes, Marfan syndrome, osteogenesis imperfecta, and achondroplasia among the many. He served as director of the Skeletal Dysplasia Center (CCHMC), co-director of the Marfan/Ehlers-Danlos Syndrome Clinic, as well as director of the Connective Tissue Clinic.
In addition, he served as associate director in the Clinical Molecular Genetics Laboratory at CCHMC. He earned a bachelor’s in science for engineering (BSE) in genetic engineering from Purdue University in 1989. He received his Ph.D. in Human Genetics from the George Washington University in the District of Columbia in 1995.
He attended medical school at Indiana University and completed a pediatric/clinical genetics residency at CCHMC. He also finished a fellowship in clinical molecular genetics at CCHMC following residency.
He formerly served on the Board of Directors and on the Professional Advisory Network of the Ehlers-Danlos National Foundation.